In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis

MLA

Katrin Deumelandt, et al. “In Vivo Nanoparticle Imaging of Innate Immune Cells Can Serve as a Marker of Disease Severity in a Model of Multiple Sclerosis.” Proceedings of the National Academy of Sciences, vol. 113, Oct. 2016, pp. 13227–32. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4f799491318b1308ceffa37cfbac44b9&authtype=sso&custid=ns315887.

APA

Katrin Deumelandt, Michael Platten, Jana K. Sonner, Martin Bendszus, Klara Kirschbaum, Julia Bode, Angelika Hoffmann, Thomas Krüwel, Manuel Fischer, Matthias W.G. Zeller, Sabine Heiland, Rakesh Sharma, Michael O. Breckwoldt, Martina U. Muckenthaler, John W. Chen, Wolfgang Wick, Björn Tews, & Milene Costa da Silva. (2016). In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis. Proceedings of the National Academy of Sciences, 113, 13227–13232.

Chicago

Katrin Deumelandt, Michael Platten, Jana K. Sonner, Martin Bendszus, Klara Kirschbaum, Julia Bode, Angelika Hoffmann, et al. 2016. “In Vivo Nanoparticle Imaging of Innate Immune Cells Can Serve as a Marker of Disease Severity in a Model of Multiple Sclerosis.” Proceedings of the National Academy of Sciences 113 (October): 13227–32. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4f799491318b1308ceffa37cfbac44b9&authtype=sso&custid=ns315887.